Skip to main content

Juno, CAR-T Peers Rise After Report Of Potential Celgene Deal

Shares of Juno Therapeutics are on the rise after the Wall Street Journal reported that the company is in talks to be acquired by Celgene.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.